Safety and efficacy of the JAK-inhibitor tofacitinib in patients with primary sclerosing cholangitis: a multicentre, retrospective study
Zeitschrift für Gastroenterologie | February 4, 2022 | Volume: 60 | Issue: 01 | Pages: e18-e18
10.1055/s-0041-1740704